Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal
about
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosisProtein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patientsPharmacokinetic/pharmacodynamic profiling of imipenem in patients admitted to an intensive care unit in India: A nonrandomized, cross-sectional, analytical, open-labeled study.Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Variability in plasma concentration of cefotaxime in critically ill patients in an Intensive Care Unit of India and its pharmacodynamic outcome: A nonrandomized, prospective, open-label, analytical studyProtein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?Changes in ceftriaxone pharmacokinetics/pharmacodynamics during the early phase of sepsis: a prospective, experimental study in the rat.Approaches for dosage individualisation in critically ill patients.Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
P2860
Q33821554-632511E3-A0F6-4851-AB9A-23B44EC863EEQ35156359-5EC30DEB-3A23-4159-A187-0A66C5D6FC53Q36072500-70D3A56C-4CCB-450E-9C8E-4E24B9EAE1BFQ36262753-3ED2C885-E228-4410-9EFC-AE97FCD8183DQ36287127-04096284-1281-4ED0-83ED-91A5D3320D6BQ36797704-064CE17A-07E7-4F6B-AA73-90596F90FD3FQ37335840-5C35D5D3-C8A9-4517-A224-4A4D5C7D0AB0Q37416986-64327EC3-C289-49E2-8007-5CA2E99BC491Q38125209-16937C2C-C6E6-4B2F-BD19-D7418A23C0CEQ38454518-AA26C67E-17A2-4934-818D-46938947D1BFQ42232248-C54E624D-FBCD-4EA7-841D-8F027FF054FEQ50503492-4214138D-F3B2-4484-A5FF-22AB7687AE2CQ58701649-220A4A17-1861-4C8D-A652-68C50F584A72
P2860
Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Population pharmacokinetics of ...... septic patients: a reappraisal
@ast
Population pharmacokinetics of ...... septic patients: a reappraisal
@en
type
label
Population pharmacokinetics of ...... septic patients: a reappraisal
@ast
Population pharmacokinetics of ...... septic patients: a reappraisal
@en
prefLabel
Population pharmacokinetics of ...... septic patients: a reappraisal
@ast
Population pharmacokinetics of ...... septic patients: a reappraisal
@en
P2093
P2860
P1476
Population pharmacokinetics of ...... septic patients: a reappraisal
@en
P2093
Chantal Le Guellec
Denis Garot
Dominique Perrotin
Emmanuelle Mercier
Nicolas Simon
Philippe Lanotte
Pierre-François Dequin
P2860
P304
P356
10.1111/J.1365-2125.2011.04005.X
P407
P577
2011-11-01T00:00:00Z